Riot Platforms, Inc. — Director's Dealing 2012

Apr 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-04-02

Reporting Person: RATAIN MARK J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-04-02	Stock Option (Right to Buy)	$0.711	A	10000	Acquired	2022-04-02	Common Stock (10000)	Direct

Footnotes

F1: The option to purchase 10,000 shares of common stock shall become exercisable as to 33.33% of the shares on each of April 2, 2013 and April 2, 2014, and as to the remaining 33.34% of the shares on April 2, 2015.